Alere (NYSE:ALR) said it recalled several of its blood clot-testing products over concerns they might provide inaccurate results that could result in serious injury or death.
According to the FDA’s website, Alere issued a recall Dec. 5 for its INRatio and INRatio2 monitors and test strips after receiving reports the devices failed to accurately measure a patient’s international normalized ratio, or INR. The products are used to determine the blood-clotting speed, or prothrombin time, in patients taking the anticoagulant drug warfarin.
Help employers find you! Check out all the jobs and post your resume.
